Ethos Labs’ Comprehensive Pain Portfolio at a Glance

Ethos Labs’ Comprehensive Pain Portfolio at a Glance

Treating patients with chronic pain is complex and developing the optimal treatment approach requires a holistic understanding of the patient. Ethos Labs’ Chronic Pain Intelligence Portfolio is purposely built to provide actionable intelligence so physicians can develop personalized treatment to better address their patients’ pain.

Our Tests


Foundation Pain Index (FPI)

FPI is the world’s first objective, non-invasive biochemical pain index that gives practitioners confidence in personalized treatment options for their patients. FPI consolidates 11 biomarker results from a single urinalysis sample into a single pain index score that describes the probability that biochemical abnormalities are contributing to a patient’s pain.

Advanced Adherence Assessment (Toxicology)

Advanced Adherence Assessment is our solution to traditional toxicology adherence testing. Our tox tests feature 24-hour turnaround times for nearly 95% of samples. These adherence tests enable physicians to ensure that patients are following their tailored treatment regimens. The same urinalysis samples that are sent for our tox testing can also be used for FPI testing.

Pharmacogenetics (PGx)

Our PGx tests enable physicians to tailor a patient’s medication regimens based on their unique genetic makeup. These insights help create more optimal treatment plans and ultimately can lead to better patient outcomes with fewer negative side effects.


How To Leverage The Ethos Labs Portfolio

By leveraging combinations of our testing portfolio, physicians can get actionable intelligence on their patients quickly and create more optimal treatment plans in a more agile manner.

For example: consider the case of a patient not responding to a prescribed SSRI. There are 3 initial possibilities that should be considered when determining what the next course of action should be:

  • Order Foundation Pain Index at intake to identify underlying deficiencies that could impact how the patient experiences pain and identify ways to support healing
  • Following supplementation, reorder Foundation Pain Index as needed to monitor patient progress
  • If medication is indicated, utilize PGx to determine the medication class with the efficacy for the patient
  • Utilize toxicology testing to ensure compliance once medication is prescribed

Interested in integrating our enhanced testing capabilities into your practice? Request a consultation here.

Go to Top